Squamous Carcinoma Poorly Differentiated
2 clinical trials · Condition
◉ Watch Squamous Carcinoma Poorly Differentiated
| Record | Firm | Date |
|---|---|---|
| Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC) (NCT07460765) | Vanderbilt-Ingram Cancer Center | 2026-07-01 |
| Outcomes of FoundationOne Directed Therapy in Cancer of Unknown Primary (NCT02628379) | Foundation Medicine | 2015-05-01 |
Track Squamous Carcinoma Poorly Differentiated automatically
Every clearance here is in the API, with alerts when new ones post.